IL244731B - From a repeated day of microtecovirimate monohydrate - Google Patents
From a repeated day of microtecovirimate monohydrateInfo
- Publication number
- IL244731B IL244731B IL244731A IL24473116A IL244731B IL 244731 B IL244731 B IL 244731B IL 244731 A IL244731 A IL 244731A IL 24473116 A IL24473116 A IL 24473116A IL 244731 B IL244731 B IL 244731B
- Authority
- IL
- Israel
- Prior art keywords
- rehydration
- micronized
- tecovirimat
- monohydrate
- tecovirimat monohydrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906119P | 2013-11-19 | 2013-11-19 | |
| PCT/US2014/065674 WO2015077143A1 (en) | 2013-11-19 | 2014-11-14 | Rehydration of micronized tecovirimat monohydrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL244731A0 IL244731A0 (en) | 2016-04-21 |
| IL244731B true IL244731B (en) | 2021-05-31 |
Family
ID=53180052
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL244731A IL244731B (en) | 2013-11-19 | 2016-03-23 | From a repeated day of microtecovirimate monohydrate |
| IL282098A IL282098B2 (en) | 2013-11-19 | 2021-04-06 | From a repeated day of microtecovirimate monohydrate |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL282098A IL282098B2 (en) | 2013-11-19 | 2021-04-06 | From a repeated day of microtecovirimate monohydrate |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10406103B2 (enExample) |
| EP (1) | EP3043793B1 (enExample) |
| JP (1) | JP6594303B2 (enExample) |
| CN (1) | CN105636585B (enExample) |
| AU (2) | AU2014353235B2 (enExample) |
| CA (1) | CA2930461C (enExample) |
| IL (2) | IL244731B (enExample) |
| WO (1) | WO2015077143A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020252284A1 (en) * | 2019-06-13 | 2020-12-17 | Imbucanna, Inc | Compressible cannabinoid pharmaceutical composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| US7687641B2 (en) * | 2003-06-20 | 2010-03-30 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| US7737168B2 (en) * | 2003-06-20 | 2010-06-15 | Siga Technologies, Inc. | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| UA97349C2 (uk) * | 2005-09-08 | 2012-02-10 | Х. Луннбэк А/С | Стійкі тверді склади сертиндолу |
| CA2685153C (en) * | 2007-04-23 | 2014-12-16 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| CN101445478B (zh) | 2008-08-22 | 2011-04-06 | 中国人民解放军军事医学科学院生物工程研究所 | 含一个结晶水的化合物st-246及其晶体与制备方法 |
| JP2011041888A (ja) * | 2009-08-20 | 2011-03-03 | Nippon Soda Co Ltd | ジェットミル粉砕条件の最適化方法 |
| EP2549871B1 (en) * | 2010-03-23 | 2018-08-22 | Siga Technologies, Inc. | Polymorphic form st-246 and methods of preparation |
| SG10202105262QA (en) * | 2010-08-05 | 2021-06-29 | Siga Technologies Inc | St-246 liquid formulations and methods |
-
2014
- 2014-11-14 US US15/027,557 patent/US10406103B2/en active Active
- 2014-11-14 AU AU2014353235A patent/AU2014353235B2/en active Active
- 2014-11-14 CN CN201480056338.7A patent/CN105636585B/zh active Active
- 2014-11-14 WO PCT/US2014/065674 patent/WO2015077143A1/en not_active Ceased
- 2014-11-14 CA CA2930461A patent/CA2930461C/en active Active
- 2014-11-14 JP JP2016522728A patent/JP6594303B2/ja active Active
- 2014-11-14 EP EP14863672.3A patent/EP3043793B1/en active Active
-
2016
- 2016-03-23 IL IL244731A patent/IL244731B/en active IP Right Grant
-
2019
- 2019-07-23 US US16/519,815 patent/US10716759B2/en active Active
- 2019-07-26 AU AU2019208252A patent/AU2019208252B2/en active Active
-
2021
- 2021-04-06 IL IL282098A patent/IL282098B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL282098A (en) | 2021-05-31 |
| CN105636585B (zh) | 2020-02-07 |
| EP3043793A1 (en) | 2016-07-20 |
| JP2016537318A (ja) | 2016-12-01 |
| EP3043793B1 (en) | 2021-01-06 |
| CN105636585A (zh) | 2016-06-01 |
| CA2930461C (en) | 2022-08-16 |
| AU2014353235A1 (en) | 2016-04-21 |
| JP6594303B2 (ja) | 2019-10-23 |
| CA2930461A1 (en) | 2015-05-28 |
| IL282098B1 (en) | 2023-01-01 |
| AU2019208252B2 (en) | 2020-03-19 |
| WO2015077143A1 (en) | 2015-05-28 |
| AU2014353235B2 (en) | 2019-05-09 |
| US10716759B2 (en) | 2020-07-21 |
| IL244731A0 (en) | 2016-04-21 |
| US10406103B2 (en) | 2019-09-10 |
| US20160235676A1 (en) | 2016-08-18 |
| IL282098B2 (en) | 2023-05-01 |
| EP3043793A4 (en) | 2017-05-10 |
| US20190380966A1 (en) | 2019-12-19 |
| AU2019208252A1 (en) | 2019-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287516A (en) | Medicinal uses of empagliflozin | |
| IL241101A0 (en) | Medicinal uses of empagliflozin | |
| GB201421334D0 (en) | Synthesis of aeizeolite | |
| IL241102A0 (en) | Medicinal uses of empagliflozin | |
| SI2981271T1 (sl) | Terapevtske uporabe empagliflozina | |
| ZA201602198B (en) | Preparation of hydroxy-benzylbenzene derivatives | |
| ZA201604502B (en) | Use of benzimidazole-proline derivatives | |
| IL244755B (en) | process to create xanthohumol | |
| IL240763A0 (en) | The halopyrazoles as thrombin inhibitors | |
| IL282098A (en) | From a repeated day of microtecovirimate monohydrate | |
| IL245259A0 (en) | Crystalline solvate forms of cabazitaxel | |
| TWM475821U (en) | Structure of mosquito-catch | |
| EP2968557A4 (en) | IMPROVING VACCINES | |
| TWM475524U (en) | Structure of rivet-pulling | |
| GB201304608D0 (en) | BenTime of Yisrael operable arrangement | |
| PL3071575T3 (pl) | Wytwarzanie normorfinanów | |
| TWM475181U (en) | Structure of shoesole | |
| GB201303276D0 (en) | Patent of gravity | |
| TWM476760U (en) | Structural improvement of storage box |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted |